Persistence ofPseudomonas aeruginosain a pulmonary nodule with late relapse-Reference-Cited by-同舟云学术

Persistence ofPseudomonas aeruginosain a pulmonary nodule with late relapse

Published:2014-06-26 Issue:4 Volume:16 Page:666-671
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Ronkainen S.¹,Xie Y.²,Battiwalla M.³,Barrett A.J.³,Stock F.⁴,Dekker J.P.⁴,Danner R.L.⁵

Affiliation:

1. Department of Medicine; University of Minnesota; Minneapolis Minnesota USA

2. Laboratory of Clinical Infectious Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda Maryland USA

3. Hematology Branch; National Heart, Lung and Blood Institute; National Institutes of Health; Bethesda Maryland USA

4. Microbiology Service; Department of Laboratory Medicine; Clinical Research Center; National Institutes of Health; Bethesda Maryland USA

5. Critical Care Medicine Department; Clinical Research Center; National Institutes of Health; Bethesda Maryland USA

Funder

NIH Clinical Center

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12253/fullpdf

Reference19 articles.

1. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients;Copp;Am J Transplant,2006

2. The pulmonary nodule after lung transplantation. Cause and outcome;End;Chest,1995

3. Lung abscess in patients with AIDS;Furman;Clin Infect Dis,1996

4. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008;Reyes;Medicine,2009

5. Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresis;Harrington;J Clin Microbiol,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing;PLOS ONE;2022-03-31